Compare CHH & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHH | SHC |
|---|---|---|
| Founded | 1939 | 2015 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Hotels/Resorts | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.5B |
| IPO Year | 1997 | 2020 |
| Metric | CHH | SHC |
|---|---|---|
| Price | $115.01 | $15.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $114.30 | $20.33 |
| AVG Volume (30 Days) | 626.2K | ★ 2.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | 27.42 | ★ 68.75 |
| EPS | ★ 0.44 | 0.09 |
| Revenue | ★ $1,596,793,000.00 | $1,163,617,000.00 |
| Revenue This Year | $66.74 | $7.51 |
| Revenue Next Year | $0.37 | $6.00 |
| P/E Ratio | $261.02 | ★ $175.28 |
| Revenue Growth | 0.75 | ★ 5.74 |
| 52 Week Low | $84.04 | $10.94 |
| 52 Week High | $136.45 | $19.85 |
| Indicator | CHH | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 57.25 | 50.75 |
| Support Level | $102.06 | $15.00 |
| Resistance Level | $116.89 | $16.47 |
| Average True Range (ATR) | 4.30 | 0.53 |
| MACD | 0.70 | -0.02 |
| Stochastic Oscillator | 80.87 | 50.61 |
At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.